Immunotherapy of melanoma with BCG: Two fatalities following intralesional injection
Open Access
- 1 February 1975
- Vol. 35 (2), 514-520
- https://doi.org/10.1002/1097-0142(197502)35:2<514::aid-cncr2820350233>3.0.co;2-f
Abstract
Two fatalities are reported following intralesional injection of BCG for immuno‐therapy of malignant melanoma. In both cases the terminal events were characterized by high fevers, major clotting defects, hypotension, and anuria, suggesting that the mechanism was hypersensitivity to BCG.Keywords
This publication has 14 references indexed in Scilit:
- GRANULOMATOUS HEPATITIS: A COMPLICATION OF B.C.G. IMMUNOTHERAPYThe Lancet, 1973
- Regional Lymphadenitis Following BCG Vaccination (BCGitis)Clinical Pediatrics, 1972
- GENERALIZED BCG TUBERCULOSIS WITH FATAL COURSE IN TWO SISTERSActa Paediatrica, 1972
- Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovisScience, 1971
- Unusual complication of B.C.G. vaccination.BMJ, 1971
- BCG-Osteomyelitis and -Osteoarthritis as a Complication Following BCG-VaccinationActa Orthopaedica, 1971
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- ALLERGIC REACTION TO B.C.G.The Lancet, 1968
- Dangers of Immunization in Immunologically Incompetent IndividualsActa Paediatrica, 1967
- Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the MouseNature, 1959